HRT Research

Menopause. 2012 Mar;19(3):257-71
The 2012 hormone therapy position statement of: The North American Menopause Society

University of Missouri 2010
Breast Cancer Risk Varies Among Different Progestins Used in Hormone Replacement Therapy, MU Researchers Finds

JAMA. 2010;304(15):1719-1720
Postmenopausal Hormone Therapy and Breast Cancer: An Uncertain Trade-off

Medscape October 19, 2010
11-Year WHI Data Show Increase in More Advanced Breast Cancers

Cancer Research October 19, 2010
Tissue-Specific Pathways for Estrogen Regulation of Ovarian Cancer Growth and Metastasis

JAMA. 2010;304(15):1684-1692
Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women

Medscape October 12, 2010
Hip Fractures Soar When Hormone Therapy Stops

Medscape October 12, 2010
Hormone Therapy Raises CHD Risk in Women With Metabolic Syndrome

Medscape October 13, 2010
Lower Doses of Estrogen in Hormone Therapy Carry Less Cardiovascular Risk

Arch Intern Med. 2010;170(18):1678-1685
Postmenopausal Hormone Use and the Risk of Nephrolithiasis

Cancer Prevention Research August 10, 2010
Synthetic Progestins Differentially Promote or Prevent 7,12-Dimethylbenz(a)anthracene–Induced Mammary Tumors in Sprague-Dawley Rats

American Association for Cancer Research August 10, 2010
New Findings Further Clarify Breast Cancer Risk With Hormone Therapy

BMJ 2010;340:c2519
Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study

ScienceDaily Feb. 19, 2010
Short-Term Heart Disease Risks of Combination Menopausal Hormone Therapy Confirmed

Endocrine-Related Cancer 2009, 16 (1) 85-98
Regression of progestin-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors in Sprague-Dawley rats by p53 reactivation and induction of massive apoptosis: a pilot study

Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD001405
Oestrogen therapy for urinary incontinence in post-menopausal women

The Lancet, Volume 374, Issue 9697, Pages 1243 - 1251, 10 October 2009
Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial

Hormone Replacement Therapy and Cardiovascular Health in the United States.
Medical Care:May 2009 - Volume 47 - Issue 5 - pp 600-606

The New England Journal of Medicine, Volume 360:573-587 February 5, 2009 Number 6
Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women

ScienceDaily (June 20, 2008)
Complex Changes In The Brain's Vascular System Occur After Menopause

Arch Intern Med. 2008;168(8):861-866.
Postmenopausal Hormone Therapy and Stroke
Role of Time Since Menopause and Age at Initiation of Hormone Therapy

Medscape March 11, 2008
Estrogen Levels Linked to Risk for Breast Cancer Recurrence

From Heart wire - a professional news service of WebMD March 5, 2008
Breast Cancer Risk Remains After Stopping HRT

ScienceDaily (Apr. 9, 2008)
Estrogen Therapy Increases Benign Breast Disease Risk, Study Suggests

University of Oxford 19 April 2007
HRT increases incidence of, and deaths from, ovarian cancer

Medscape Medical News April 24, 2007 (login required)
Hormone Replacement Therapy Linked to Ovarian Cancer

Metabolism Volume 56, Issue 6, June 2007, Pages 830-837
Addition of medroxyprogesterone acetate to conjugated equine estrogens results in insulin resistance in adipose tissue

JAMA. 2007 Apr;297(13):1465-77
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

The FASEB Journal 2007;21:2285-2293.
Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer

CANCERactive Published 2007
Dramatic fall in Breast Cancer rates points finger at HRT again

JOURNAL OF CLINICAL ONCOLOGY
VOLUME 24 NUMBER 33 NOVEMBER 20 2006
Recent Declines in Hormone Therapy Utilization and Breast Cancer
Incidence: Clinical and Population-Based Evidence

Maturitas Volume 52, Issue 1, 16 September 2005, Pages 1-10
New evidence regarding hormone replacement therapies is urgently required. Transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits

JNCI Journal of the National Cancer Institute 2005 97(8):595-602;
Plasma Sex Hormone Concentrations and Subsequent Risk of Breast Cancer Among Women Using Postmenopausal Hormones

CELLULAR AND MOLECULAR LIFE SCIENCES Volume 62, Number 3 (2005), 255-256
Alzheimer's disease: the impact of age-related changes in reproductive hormones

Maturitas Volume 49, Issue 4, 10 December 2004, Pages 315-320
Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women

JAMA. 2004;291:47-53.
National Use of Postmenopausal Hormone Therapy
Annual Trends and Response to Recent Evidence

Biological Psychiatry
Volume 55, Issue 4, 15 February 2004, Pages 406-412
Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial

BMJ 2004;328:357-358 (14 February), doi:10.1136/bmj.328.7436.357
Where are we now with hormone replacement therapy?

Annals of Internal Medicine
3 February 2004 | Volume 140 Issue 3 | Pages 184-188
Changes in the Use of Postmenopausal Hormone Therapy after the Publication of Clinical Trial Results

Medscape Dec. 15, 2003
Estrogen Plus Progestin Doubles Risk of Venous Thrombosis

The Lancet Volume 362, Issue 9382, 9 August 2003, Pages 428-432
Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

The Lancet, Volume 362, Issue 9382, 9 August 2003, Pages 414-415
Breast cancer and hormone-replacement therapy in the Million Women Study

Cancer Causes and Control
Volume 14, Number 2 / March, 2003 , 195-201
Patterns of postmenopausal progestin use with estrogen in relation to endometrial cancer

BJOG: An International Journal of Obstetrics and Gynaecology
Volume 109 Issue 9 Page 1056 - September 2002
A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT Atherosclerosis Study